English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Shire

Nicholas Gueguen | Jun 30, 2017

Shire study sees reduction in hereditary angioedema episodes using lanadelumab

Ruth de Jauregui | May 3, 2017

Study indicates one bleeding incident every 3-15 seconds among hemophiliacs

Robert Hadley | Apr 28, 2017

Shire’s hashtag campaign focusing on primary immunodeficiency

Keri Carbaugh | Feb 6, 2017

Shire takes lead on rare conditions, CEO says

Keri Carbaugh | Jan 18, 2017

Shire again offers scholarship for students with ADHD

Amanda Rupp | Jun 11, 2016

Shire shareholders approve Baxalta merger

Amanda Rupp | Jun 7, 2016

CHMP gives positive opinion of short bowl syndrome pediatric medicine

Amanda Rupp | Apr 17, 2016

Shire sends application to FDA for chewable Vyvanse tablets

Trending

Patient Daily | Jul 24, 2025

Long School of Medicine is largest physician trainer in South Texas

Patient Daily | Jul 25, 2025

Healthcare CEO on 340B reform: ‘It’s the abuse by very large, very profitable, tax-exempt institutions that I think needs to change'

+ Pharmaceuticals
Patient Daily | Jul 22, 2025

Deputy VP of Public Affairs of PhRMA: 'It's time for Congress to fix the 340B Drug Pricing Program'

Patient Daily | Jul 25, 2025

Balloon sinuplasty marks 20 years since FDA approval



Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily